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Organ progenitors arise within organ fields, em-
bryonic territories that are larger than the re-
gions required for organ formation. Little is
known about the regulatory pathways that
define organ field boundaries and thereby limit
organ size. Herewe identify amechanism for re-
stricting heart size through confinement of the
developmental potential of the heart field. Via
fate mapping in zebrafish, we locate cardiac
progenitors within hand2-expressing meso-
derm and demonstrate that hand2 potentiates
cardiac differentiation within this region. Be-
yond the rostral boundary of hand2 expression,
we find progenitors of vessel and blood line-
ages. In embryos deficient in vessel and blood
specification, rostral mesoderm undergoes
a fate transformation and generates ectopic
cardiomyocytes. Therefore, induction of vessel
and blood specification represses cardiac
specification and delimits the capacity of the
heart field. This regulatory relationship between
cardiovascular pathways suggests strategies
for directing progenitor cell differentiation to
facilitate cardiac regeneration.
INTRODUCTION
Organogenesis relies upon the production of a proper
number of progenitor cells. A shortage of progenitors
can limit organ size and functional capacity, whereas
a surplus of progenitors can lead to organ enlargement
and dysfunction. Organ progenitors are thought to arise
within ‘‘organ fields,’’ embryonic territories that possess
the appropriate developmental potential but are typically
larger than the regions fated to contribute to the organ
(Huxley and De Beer, 1934; Jacobson and Sater, 1988).
Therefore, progenitor quantity is likely to be controlled
by the establishment of field boundaries and the gradual
refinement of field potential. However, the regulation of
these processes is not well understood.
Enthusiasm for the possibilities of regenerative medi-
cine has fueled interest in the mechanisms that create
and differentiate organ progenitors. For instance, identifi-254 Developmental Cell 13, 254–267, August 2007 ª2007 Elsecation of a source for cardiac progenitors could facilitate
cellular therapy aimed at regeneration of cardiac muscle
(Laflamme and Murry, 2005; van Laake et al., 2006). The
origins of cardiac progenitors have therefore attracted
particular attention. Fate mapping studies have shown
that cardiac progenitors reside within bilateral heart-
forming regions (HFRs) of the anterior lateral plate meso-
derm (ALPM) (Harvey, 2002; Yutzey and Kirby, 2002).
The HFRs are the primary source of the cardiomyocytes
that compose the initial heart tube. In Xenopus and zebra-
fish, the HFRs are the only reported mesodermal source of
cardiomyocytes (Raffin et al., 2000; Serbedzija et al.,
1998). In contrast, chick and mouse embryos contain
a second source of cardiomyocytes in a separate meso-
dermal territory. This region, called the second, or ante-
rior, heart field, contributes myocardium to the arterial
and venous poles of the heart, including contributions to
the outflow tract, right ventricle, and atria (Buckingham
et al., 2005; Kelly et al., 2001; Mjaatvedt et al., 2001;
Waldo et al., 2001; Cai et al., 2003; Zaffran et al., 2004).
To date, the embryonic and evolutionary origins of the
second heart field remain unclear.
In frog and fish, the ALPM surrounding the HFRs ap-
pears to exhibit the breadth of developmental potential
expected of an organ field. In Xenopus, extirpated tissue
from a lateral portion of the ALPM can produce cardio-
myocytes in vitro, even though this particular region
does not normally produce cardiomyocytes in vivo (Sater
and Jacobson, 1990; Raffin et al., 2000; Garriock and
Drysdale, 2003). In zebrafish, removal of the anterior noto-
chord allows cardiac specification in ALPM just caudal to
the HFRs (Goldstein and Fishman, 1998). Furthermore, ze-
brafish HFRs can rapidly be replenished after partial abla-
tion, due to contributions from rostral ALPM flanking these
regions (Serbedzija et al., 1998). Together, these studies
indicate that the cardiogenic potential of the ALPM ex-
tends beyond the boundaries of the genuine HFRs.
It is unclear how certain portions of the ALPM are kept
from fulfilling their cardiac potential. A few pathways
have been implicated in the repression of cardiac fate as-
signment. For example, Notch signaling seems to inhibit
cardiac specification in lateral portions of the Xenopus
ALPM (Rones et al., 2000). Canonical Wnt signaling has
also been suggested to repress cardiac potential in chick,
Xenopus, and mouse (Marvin et al., 2001; Schneider and
Mercola, 2001; Lickert et al., 2002). Finally, retinoic acid
signaling appears to restrict the specification of cardiacvier Inc.
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Repression of Cardiac Potential in ZebrafishFigure 1. Gene Expression Patterns
Divide the ALPM into Three Territories
(A–K) Two-color fluorescent in situ hybridiza-
tion of wild-type embryos at the 7 somite
stage, dorsal views, anterior to the top. All im-
ages are shown at the same magnification; the
scale bar represents 100 mm.
(A) Overlay of gata4 (B) and hand2 (C) expres-
sion. Expression of hand2 is observed through-
out the caudal portion of gata4-expressing
ALPM, but is excluded from the rostral ALPM.
(D) Overlay of gata4 (E) and nkx2.5 (F) expres-
sion. Expression of nkx2.5 is observed within
a medial portion of the caudal ALPM, but is ex-
cluded from the lateral and rostral ALPM.
(G) Overlay of gata4 (H) and scl (I) expression.
Expression of scl is observed in the rostral
ALPM.
(J) Overlay of hand2 (green) and scl (red)
expression. Expression patterns of scl and
hand2 do not overlap.
(K) Overlay of hand2 (green) and nkx2.5 (red)
expression. Expression of hand2 extends be-
yond the lateral limit of nkx2.5 expression.
(L) Schematic of 7 somite stage ALPM, super-
imposed onto a dorsal view of a live embryo;
dashes outline the tip of the notochord. Com-
parison of gene expression patterns defines
rostral (white), medial (black), and lateral
(gray) ALPM territories. Although ALPM mor-
phology varies slightly during the 6–9 somite
stage and between individual embryos, relative
patterns of gene expression consistently de-
marcate these territories.progenitors during gastrulation stages in zebrafish and
Xenopus (Keegan et al., 2005; Collop et al., 2006) and to
inhibit cardiomyocyte differentiation within the ALPM in
Xenopus and chick (Osmond et al., 1991; Yutzey et al.,
1994; Drysdale et al., 1997). It is not known whether or
how these pathways work together to refine the cardio-
genic potential of the heart field, and it is likely that impor-
tant repressive influences remain to be revealed.
Here we identify a potent mechanism for restricting car-
diac specification within the heart field. By constructing
a fate map of the zebrafish ALPM, we establish that the
boundaries of the zebrafish HFR correspond to the
boundaries of hand2 expression. Mesoderm beyond the
rostral limit of hand2 expression normally gives rise to ves-
sel and blood lineages. However, this rostral territory also
harbors latent cardiac developmental potential. Embryos
with defects in vessel and blood specification exhibit too
many cardiomyocytes, and these extra cells are the con-
sequence of a fate transformation that generates ectopic
cardiac progenitors in rostral mesoderm. These data dem-
onstrate an important regulatory relationship between theDevelodevelopmental programs that create the cardiovascular
system: components of the vessel and blood specification
pathways repress cardiac specification and thereby limit
heart size. This interplay between pathways has implica-
tions for the mechanisms underlying cardiac evolution
and suggests new strategies for regenerative medicine.
RESULTS
Gene Expression Patterns Divide the ALPM
into Three Territories
In order to investigate the mechanisms that delimit cardiac
potential in zebrafish, we first sought to define the dimen-
sions of the HFR relative to gene expression patterns in
the zebrafish ALPM. We chose to examine the expression
of a group of transcription factor genes at the 6–9 somite
stage (Figure 1), 3–4 hr prior to the onset of myocardial dif-
ferentiation (Yelon et al., 1999). At these stages, the ALPM
appears as bilateral strips of tissue running along the lat-
eral edges of the embryonic anterior-posterior axis. A
few genes (e.g., gata4, gata5, and tbx20) are expressedpmental Cell 13, 254–267, August 2007 ª2007 Elsevier Inc. 255
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(A–I) Dorsal views, anterior to the top, of wild-type embryos at the 6–9 somite stage. The scale bars represent 100 mm.
(A–C) Photoactivation of caged fluorescein labels groups of cells in the ALPM.
(A) DIC image of a live embryo. The lateral edge of the ALPM (dashed line) is visible.
(B) Fluorescence indicates photoactivation of caged fluorescein.
(C) Overlay of DIC and fluorescent images confirms location of labeled cells. In this example, the 14 labeled cells reside in the medial ALPM.
(D and G) Schematics indicate ALPM regions that were interrogated by fate mapping.
(D) Two regions within the rostral ALPM were examined, on both sides of the embryo: a region flanking the forebrain (region 1) and a region flanking the
midbrain-hindbrain boundary (region 2).
(E and F) Examples of control experiments performed to assess the accuracy of labeling rostral ALPM. Cells were labeled in the regions depicted by
green ovals in (D) and immediately processed to compare scl expression (red) relative to uncaged fluorescein (green).
(E) Cells labeled in region 2 were located solely within the scl expression domain in 5/9 experiments; in the other four experiments, labeling crossed the
posterior border of scl expression and therefore overlapped with hand2-expressing territory.
(F) Cells labeled in region 1 were located within the scl expression domain in 8/8 experiments.
(G) Eight regions within the caudal ALPM were examined, on both sides of the embryo: four medial regions and four lateral regions are distinguished
by their position along the anterior-posterior axis.256 Developmental Cell 13, 254–267, August 2007 ª2007 Elsevier Inc.
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not shown). In contrast, expression of hand2 is confined
to a relatively posterior portion of the ALPM, flanking the
hindbrain and extending below the tip of the notochord
(Figures 1A–1C). Expression of hand2 in this portion of
the ALPM spans its width (Figures 1A–1C). This region is
subdivided by nkx2.5 expression, which is prominently ex-
pressed medially but not detectable laterally (Figures 1D–
1F and 1K). We find expression of genes associated with
vasculogenesis and hematopoiesis (e.g., scl, fli1a, spi1,
and lmo2) anterior to hand2, in the most rostral portion
of the ALPM (Figures 1G–1J, and data not shown). Ex-
pression of rostral ALPM genes has no detectable overlap
with hand2 expression (Figure 1J). Thus, gene expression
patterns divide the ALPM into three distinct territories,
hereafter referred to as medial, lateral, and rostral ALPM
(Figure 1L).
Constructing a Fate Map of ALPM Territories
Next, we investigated where cardiac progenitors reside
within the three ALPM territories. Medial ALPM has previ-
ously been shown to contain cardiac progenitors (Serbed-
zija et al., 1998), but the cardiac contributions of lateral
and rostral ALPM have not been explored. To construct
a fate map of the ALPM, we employed a photoactivatable
DMNB-caged fluorescein dextran conjugate as a lineage
tracer. By adapting a photoactivation protocol previously
used for fate mapping at late blastula stages (Keegan
et al., 2004), we labeled cells within the ALPM at the 6–9
somite stage (Figures 2A–2C) and later assessed their
fate (Figures 2J–2L). In each experimental embryo, we la-
beled a cluster of 10–15 cells within a particular region: we
examined two regions within the rostral ALPM (Figure 2D),
four regions within the medial ALPM (Figure 2G), and four
regions within the lateral ALPM (Figure 2G). Use of visible
anatomical landmarks, such as the lateral edge of the
ALPM, notochord, and brain structures, facilitated accu-
rate targeting of each region (Figures 2D–2I). Following
heart formation, embryos were fixed and processed to
score contributions of labeled cells to the myocardium
(Figure 2J) and endocardium (Figure 2L). We also noted
contributions to other mesodermal tissues, including
head vessels, head mesenchyme, and myeloid cells. Ad-
ditionally, many experimental embryos exhibited labeled
progeny within the pharyngeal pouches (Figure 2K); pha-
ryngeal pouch labeling is likely to reflect overlap of the mi-
grating anterior endoderm and the ALPM at the 6–9 somite
stage (Wendl et al., 2007).DeveloThe Zebrafish HFR Extends across Medial
and Lateral Territories
Our fate map data demonstrate the presence of myocar-
dial progenitors within both medial and lateral ALPM terri-
tories (Figure 3). Seventy-two percent of experiments in
medial ALPM generated labeled myocardial progeny
(Figure 3B; Table 1). Similarly, 66% of experiments in lat-
eral ALPM generated myocardial progeny (Figure 3B; Ta-
ble 1). In contrast, only 9% of experiments in rostral ALPM
generated myocardial progeny (Figure 3B; Table 1). In-
stead, we found labeled endocardial progeny in 40% of
rostral ALPM experiments (Figure 3B; Table 1). In rostral
ALPM experiments that generated myocardial progeny,
labeled cells were located near the boundary between
scl and hand2 expression and not in the most rostral re-
gion tested (Figures 3A and 3B; Table 1), suggesting that
the myocardial progenitors labeled alongside the scl/
hand2 border might have originated in hand2-expressing
ALPM. Thus, our data indicate that the zebrafish HFR ex-
tends across medial and lateral ALPM, with little or no con-
tribution from rostral ALPM.
Although myocardial progenitors arise in both medial
and lateral ALPM, our fate map indicates a striking differ-
ence between the chamber identities of the cardiomyo-
cytes derived from these two territories. Of the medial
ALPM experiments that produced myocardial progeny,
96% of embryos exhibited labeled cardiomyocytes in
the ventricle, whereas only 38% of embryos exhibited la-
beled cardiomyocytes in the atrium (Figure 3C; Table 1).
The converse was observed in lateral ALPM experiments
that produced myocardial progeny: only 19% of embryos
contained labeled ventricular cardiomyocytes, whereas
98% of embryos contained labeled atrial cardiomyocytes
(Figure 3C; Table 1). These data demonstrate a general
medial-lateral organization of ventricular and atrial myo-
cardial progenitors within the HFR, consistent with the
previously documented spatial organization of ventricular
and atrial progenitors in the late blastula (Keegan et al.,
2004) and medial-lateral pattern of ventricular myosin
heavy chain and atrial myosin heavy chain expression as
myocardial differentiation proceeds in the ALPM (Yelon
et al., 1999; Berdougo et al., 2003).
Combining our fate map and gene expression data, we
conclude that the rostral and mediolateral boundaries of
the HFR correspond well with the boundaries of hand2 ex-
pression. Although previous studies have suggested that
nkx2.5 expression marks the zebrafish HFRs (Serbedzija
et al., 1998), the larger domain of hand2 expression(H and I) Examples of control experiments performed to assess mediolateral labeling accuracy. Cells were labeled in the regions depicted by green
ovals in (D) and immediately processed to compare nkx2.5 expression (red) relative to uncaged fluorescein (green).
(H) Cells labeled in lateral regions did not express nkx2.5 (n = 8/9).
(I) Conversely, cells labeled in medial regions did express nkx2.5 (n = 6/6).
(J–L) Scoring progeny of labeled ALPM cells at 44 hpf. In situ hybridization indicates expression of cmlc2 (magenta) in cardiomyocytes, and immu-
nohistochemistry for uncaged fluorescein (blue) indicates progeny of labeled cells. The scale bar represents 100 mm.
(J) Frontal view, dorsal to the top; in this example, labeled cells became 30 atrial cardiomyocytes (black arrowheads).
(K and L) Lateral views, anterior to the right.
(K) In this example, 30–40 labeled cells populated a pharyngeal pouch (white arrow).
(L) In this example, 3–4 labeled cells (black arrow) contributed to the ventricular endocardium.pmental Cell 13, 254–267, August 2007 ª2007 Elsevier Inc. 257
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tors within ALPM Territories
Schematics depicting the progenitor composi-
tion of medial, lateral, and rostral ALPM territo-
ries. Dorsal views are of the right side of the
ALPM, anterior to the top.
(A) Schematic of gene expression patterns that
distinguish medial (black), lateral (gray), and
rostral (white) ALPM territories, as in Figure 1L.
(B) Myocardial progenitors arise from medial
and lateral territories and are only rarely de-
tected in rostral territory. In contrast, endocar-
dial progenitors arise from rostral territory. For
each region tested, pie charts depict the pro-
portions of experimental embryos exhibiting
a particular type of labeled progeny. Colored
pie pieces represent embryos that produced
labeled myocardial progeny (blue), labeled en-
docardial progeny (pink), both myocardial and
endocardial labeled progeny (maroon), and
only noncardiac labeled progeny (green).
Data shown are a merger of experiments
from the left and right sides of the embryo;
our data did not reveal any left-right asymmetry
of the fate map.
(C) Ventricular and atrial myocardial progeni-
tors appear spatially organized within the cau-
dal ALPM, with ventricular progenitors tending
to originate medially and atrial progenitors
tending to originate laterally. Pie charts depict
the chamber contributions of labeled cells in
the subset of experimental embryos containing labeled myocardial progeny. Colored pie pieces represent embryos that produced labeled ventricular
cardiomyocytes (red), labeled atrial cardiomyocytes (yellow), and both ventricular and atrial cardiomyocytes (brown). See Table 1 for data reflected in
schematics.more accurately reflects HFR dimensions and includes
atrial progenitors during the 6–9 somite stage. At later
stages, however, nkx2.5 is expressed in both ventricular
and atrial myocardium (Yelon et al., 1999). Similarly, fate
maps of the chick HFR have indicated that myocardial
progenitors, mostly of atrial identity, reside beyond the
boundary of Nkx2-5 expression in the early ALPM (Redkar
et al., 2001; Hochgreb et al., 2003).
Hand2 Potentiates Myocardial Differentiation
within the HFR
Given the correlation of hand2 expression with the dimen-
sions of the HFR, we examined the function of Hand2
within this region. Our previous analyses of zebrafish
hands off/hand2 (han) mutants have suggested that
Hand2 plays a permissive role in promoting cardiomyo-
cyte production, rather than an instructive role in assigning
myocardial identity: han mutants contain few cardiomyo-
cytes, but ectopic expression of hand2 does not seem
to create ectopic cardiomyocytes (Yelon et al., 2000).
Consistent with this proposed role, we find that loss of
Hand2 function does not affect the overall dimensions of
the HFR. Initial patterns of gene expression within the
ALPM appear normal in han mutants (compare Figures
4A–4F to Figures 1D–1I). Notably, nkx2.5 expression is
not diminished (Figures 4A–4C; Yelon et al., 2000), and
scl expression does not expand caudally (Figures 4D–
4F). Additionally, fate mapping shows that myocardial258 Developmental Cell 13, 254–267, August 2007 ª2007 Elseprogenitors reside throughout the medial and lateral
ALPM territories in han mutants (Figure 4I). However, the
han mutant HFR is significantly less effective than the
wild-type HFR at producing cardiomyocytes: only 39%
of fate mapping experiments in the han mutant HFR gen-
erated labeled cardiomyocytes, compared to 69% of
experiments in the wild-type HFR (Figures 3B and 4I;
Table 1; p < 0.05, Student’s t test). Instead, labeled cells
from the han mutant HFR were often found adjacent to dif-
ferentiated cardiomyocytes (black arrowheads in Figures
4G and 4H); we detected these cells in 76% of han mutant
experiments, and did not find similar cells in wild-type
embryos. Although these flanking cells do not express ter-
minal myocardial differentiation markers such as cmlc2,
they are found in a region where many cells express
nkx2.5 (Figures 4M–4O), suggesting that they could repre-
sent cardiac progenitors that initiate, but fail to complete,
myocardial differentiation. Thus, although not required to
set HFR boundaries, Hand2 plays an important role in
the potentiation of myocardial differentiation within the
HFR.
Ectopic Cardiomyocytes Arise from Rostral
ALPM in cloche Mutants
Even though Hand2 does not appear to be responsible
for cardiac specification, hand2 expression does seem
to be a useful marker of the location of the HFR. We
hypothesized that genes critical for delimiting cardiacvier Inc.
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Genotype Region
Myocardial
Progeny (%)
Ventricular
Only (%)
Ventricular
and Atrial (%)
Atrial
Only (%)
Endocardial
Progeny (%)
Myocardial and
Endocardial (%)
Wild-type 1R 0/21(0) – – – 7/21 (33) –
2R 3/24 (12) 2/4 (50) 1/4 (25) 1/4 (25) 10/24 (42) 1/24 (4)
clo 1R 4/7 (57) 1/4 (25) 3/4 (75) 0/4 (0) – –
2R 8/9 (89) 0/8 (0) 7/8 (88) 1/8 (12) – –
Wild-type 3M 23/29 (79) 16/23 (70) 7/23 (30) 0/23 (0) – –
4M 13/20 (65) 8/13 (62) 5/13 (38) 0/13 (0) – –
5M 21/31 (68) 15/21 (71) 6/21 (29) 0/21 (0) – –
6M 14/19 (74) 5/14 (36) 6/14 (43) 3/14 (21) – –
han 3M 1/2 (50) – – – – –
4M 3/6 (50) – – – – –
5M 3/5 (60) – – – – –
6M 1/4 (25) – – – – –
Wild-type 3L 15/24 (62) 1/15 (7) 4/15 (27) 10/15 (67) – –
4L 22/30 (73) 0/22 (0) 3/22 (14) 19/22 (86) – –
5L 14/18 (78) 0/14 (0) 2/14 (14) 12/14 (86) – –
6L 7/16 (44) 0/7 (0) 1/7 (14) 6/7 (86) – –
han 3L 1/2 (50) – – – – –
4L 3/9 (33) – – – – –
5L 2/6 (33) – – – – –
6L 1/4 (25) – – – – –
For each region examined, data indicate the fraction of experimental embryos exhibiting myocardial progeny (but not endocardial
progeny), endocardial progeny (but not myocardial progeny), or both myocardial and endocardial progeny. Noncardiac progeny
detected in these experiments included pharyngeal pouches, head vessels, head mesenchyme, and myeloid cells. In medial
and lateral ALPM, >90% of all experimental embryos exhibited labeled pharyngeal pouch cells. For wild-type and clo mutant
embryos containing labeled cardiomyocytes, additional data indicate whether these cells were found only in the ventricle, only
in the atrium, or in both chambers. The dysmorphic nature of han mutant myocardium prevented morphological analysis of
chamber contributions. Data collected from left and right ALPM are combined for all regions.developmental potential would also regulate the extent of
hand2 expression. We therefore proceeded to analyze the
expression of hand2 in a collection of zebrafish mutants
with cardiac defects (Alexander et al., 1998), and discov-
ered that mutation of the cloche (clo) locus has a striking
effect on the regulation of hand2. Specifically, we found
that hand2 expression in clo mutants extends beyond its
normal boundary, exhibiting strong expression throughout
the rostral ALPM (Figures 5A and 5B). This ectopic expres-
sion does not represent a distortion of ALPM morphology,
as ALPM shape and size appear normal in clo mutants
(Figures 5C and 5D). The molecular identity of the clo
gene has yet to be reported, but previous studies have
demonstrated that clo is required for specification of en-
dothelial and hematopoietic lineages (Stainier et al.,
1995; Liao et al., 1997, 1998, 2000; Parker and Stainier,
1999; Lieschke et al., 2002; Sumanas et al., 2005; Thomp-
son et al., 1998). Interestingly, progenitors for several of
the cell types absent in clo mutants—endocardial cells,
head vessels, and myeloid cells—originate within the ros-Developtral ALPM (Figure 3B; Table 1) (Herbomel et al., 1999;
Lieschke et al., 2002; Hsu et al., 2004).
The rostral extension of hand2 expression in clo mu-
tants suggested that these embryos might contain ex-
panded HFRs. Consistent with this idea, we found that
clo mutants produce extra cmlc2-expressing cells, many
of which extend rostrally beyond the primary bilateral pop-
ulations of cardiomyocytes (Figures 5E and 5F). These ex-
tra cells require Hand2 for their efficient differentiation, just
like wild-type cardiomyocytes (see Figure S1 in the Sup-
plemental Data available with this article online): han;clo
double mutants exhibit expanded nkx2.5 expression, like
clo mutants, but only exhibit a small number of differenti-
ated cardiomyocytes, like han mutants. Extra cardiomyo-
cytes are also evident within the clo mutant heart at later
stages. By 48 hours postfertilization (hpf), the clo mutant
heart is markedly dysmorphic, with a misshapen, compact
ventricle and a dilated atrium (Figures 5G and 5H), pheno-
types that had been attributed to the loss of endocardium
(Stainier et al., 1995). Comparison of the number ofmental Cell 13, 254–267, August 2007 ª2007 Elsevier Inc. 259
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(A–F) ALPM territories appear to be established normally in han mutant embryos. Two-color fluorescent in situ hybridization of han mutants at the 7
somite stage, dorsal views, anterior to the top. The scale bar represents 100 mm.260 Developmental Cell 13, 254–267, August 2007 ª2007 Elsevier Inc.
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Cardiomyocytes
(A–H) In situ hybridization depicts expression
of hand2 (A and B), gata4 (C and D), and
cmlc2 (E–H) in wild-type (A, C, E, and G) and
clo mutant (B, D, F, and H) embryos.
(A–F) Dorsal views, anterior to the top, at the 7
somite (A–D) and 19 somite (E and F) stages.
The scale bars represent 100 mm.
(A and B) hand2 is ectopically expressed in the
rostral ALPM of clomutant embryos (arrows; [B]).
(C and D) Expression ofgata4 is indistinguishable
between wild-type andclomutant embryos, indi-
cating normal rostral ALPM morphology.
(E and F) clo mutants exhibit a rostral exten-
sion of cmlc2 expression (arrows).
(G and H) Frontal views, dorsal to the top. At 48
hpf, the wild-type heart is looped, with morpho-
logically distinct chambers, whereas the clo
mutant heart appears unlooped, with a small,
compact ventricle and a large, dilated atrium.
(I–K) clo mutant hearts contain too many cardi-
omyocytes. The scale bar represents 100 mm.
(I and J) Frontal views of hearts at 52 hpf. Im-
munofluorescence indicates that both cham-
bers express the transgene Tg(cmlc2:DsRed2-
nuc) (red) (Mably et al., 2003). Atria are labeled
with the anti-Amhc antibody S46 (aqua) (Ber-
dougo et al., 2003).
(K) Counting of cardiomyocyte nuclei reveals
a statistically significant increase (asterisk) in
the number of atrial cardiomyocytes in clo
mutants (p < 0.002, Student’s t test; n = 11 of each genotype). The bar graph indicates mean and standard error of each data set.
(L and M) Fate map of the rostral ALPM in clo mutants indicates formation of ectopic myocardial progenitors. The scale bar represents 100 mm.
(L) Frontal view of clo mutant embryo at 44 hpf, dorsal to the top. In situ hybridization indicates expression of cmlc2 (magenta) in cardiomyocytes,
and immunohistochemistry for uncaged fluorescein (blue) indicates progeny of labeled cells. In this example, labeled cardiomyocytes are found in
the atrium (black arrowheads) and in the ventricle (white arrowhead).
(M) Fate map of clo mutant rostral ALPM. For each region tested, pie charts depict the proportions of experimental embryos producing labeled myo-
cardial progeny (blue) and only noncardiac labeled progeny (green). See Table 1 for data reflected in schematic. In clo mutants, both rostral ALPM
regions frequently gave rise to cardiomyocytes, indicating a significant fate transformation (compare to Figure 3B). We have not performed fate map
experiments in the clo mutant medial or lateral ALPM, as clo mutants do not seem to exhibit significant changes in gene expression patterns in these
territories (our unpublished data).cardiomyocytes expressing the transgene Tg(cmlc2:
DsRed2-nuc) (Mably et al., 2003) demonstrated a trend to-
ward a surplus of cardiomyocytes in clo mutant heartsDevelo(Figures 5I–5K). In particular, clo mutants exhibit a statisti-
cally significant increase in the number of atrial cardio-
myocytes compared to wild-type embryos (Figure 5K).(A) Overlay of gata4 (B) and nkx2.5 (C) expression.
(D) Overlay of gata4 (E) and scl (F) expression. Expression patterns of gata4, nkx2.5, and scl divide the han mutant ALPM into normally proportioned
rostral, medial, and lateral regions.
(G–I) Fate map of the caudal ALPM in han mutants indicates that Hand2 is required to facilitate effective differentiation of myocardial progenitors from
medial and lateral ALPM territories.
(G and H) Dorsal views of han mutant embryos at 30 hpf, anterior to the top. In situ hybridization indicates expression of cmlc2 (magenta) in cardi-
omyocytes, and immunohistochemistry for uncaged fluorescein (blue) indicates progeny of labeled cells. In han mutants, labeled cells from caudal
ALPM can give rise to cardiomyocytes (white arrowhead; [H]) but also frequently become seemingly undifferentiated cells (black arrowheads; [G and
H]) flanking the cardiomyocytes. Labeled cells also contribute to pharyngeal pouches (arrows; [G and H]).
(I) Fate map of han mutant caudal ALPM. For each region tested, pie charts depict the proportions of experimental embryos producing labeled myo-
cardial progeny (blue) and only noncardiac labeled progeny (green). Myocardial progenitors were found in all regions examined, but the frequency
with which labeled han mutant ALPM produced cardiomyocytes was reduced, relative to wild-type, throughout both medial and lateral territories
(compare to Figure 3B). See Table 1 for data reflected in schematic.
(J–O) han mutants exhibit ineffective myocardial differentiation. Two-color fluorescent in situ hybridization at 24 hpf, dorsal views, anterior to the top.
The scale bar represents 100 mm.
(J and M) Overlays of cmlc2 (K and N) and nkx2.5 (L and O) expression. In wild-type embryos (J–L), cmlc2 and nkx2.5 are both expressed throughout
the heart tube. Additional expression of nkx2.5 marks the forming pharyngeal pouches (asterisks).
(M–O) In han mutants, a reduced number of cardiomyocytes span the midline. Undifferentiated, nkx2.5-expressing ALPM cells (arrows) flank the car-
diomyocytes.pmental Cell 13, 254–267, August 2007 ª2007 Elsevier Inc. 261
Developmental Cell
Repression of Cardiac Potential in ZebrafishThe number of ventricular cardiomyocytes appears rela-
tively unaffected (Figure 5K).
The ectopic hand2 expression and myocardial surplus,
together with the previously demonstrated vessel and
blood deficiencies (Stainier et al., 1995; Liao et al., 1997,
1998, 2000; Parker and Stainier, 1999; Lieschke et al.,
2002; Sumanas et al., 2005; Thompson et al., 1998), led
us to suspect that the excess cardiomyocytes in
clo mutants could arise from a fate transformation of
rostral ALPM. To test this, we examined the clo mutant
rostral ALPM fate map. As shown above, wild-type
rostral ALPM rarely contains myocardial progenitors (9%
of rostral ALPM experiments; Figure 3B; Table 1). In strong
contrast, 75% of experiments in clo mutant rostral ALPM
generated labeled myocardial progeny (Figure 5M; Table
1). In these embryos, labeled cardiomyocytes were fre-
quently found in both chambers (Table 1), indicating that
the clo mutant rostral ALPM contains both ventricular
and atrial myocardial progenitors. However, labeled atrial
cardiomyocytes typically outnumbered labeled ventricular
cardiomyocytes (Figure 5L). This may reflect an important
role of endocardial-myocardial signaling during ventricular
chamber maturation and growth, after the heart tube is as-
sembled; this function of the endocardium has been sug-
gested by previous studies in mouse (e.g., Lavine et al.,
2005; Grego-Bessa et al., 2007). Overall, our fate map
data clearly demonstrate a fate transformation within the
rostral ALPM of clo mutants: rather than producing pro-
genitors of endothelial and hematopoietic lineages, this
territory produces ectopic myocardial progenitors. There-
fore, clo acts as a repressor of cardiac specification in the
rostral ALPM.
Latent Cardiac Potential Revealed by Inhibition
of Vasculogenesis and Hematopoiesis
Prior studies of clo mutants have suggested that clo func-
tions atop a hierarchy of genes controlling vessel and
blood development (Stainier et al., 1995; Liao et al.,
1997, 1998; Thompson et al., 1998). We therefore won-
dered whether downstream components of these genetic
pathways could, like clo, act to repress rostral expression
of hand2 and cmlc2. We chose to investigate whether the
genes scl and etsrp could play this role. Both scl and etsrp
encode transcription factors and are expressed in the ros-
tral ALPM (Figures 1G–1J) (Gering et al., 1998; Liao et al.,
1998; Sumanas and Lin, 2006; Pham et al., 2007). Loss-
of-function studies have shown that Scl and Etsrp are
essential components of rostral vasculogenic and myelo-
poietic specification programs (Patterson et al., 2005;
Dooley et al., 2005; Juarez et al., 2005; Sumanas and
Lin, 2006). Additionally, overexpression of these genes
can induce ectopic expression of vessel and blood
markers (Gering et al., 1998; Dooley et al., 2005; Pham
et al., 2007; Sumanas and Lin, 2006); furthermore, overex-
pression of scl together with lmo2 induces broad, ectopic
vessel and blood specification at the expense of other
mesodermal cell types, including myocardium (Gering
et al., 2003). Both scl and etsrp act downstream of clo:
their expression is dramatically reduced in clo mutants,262 Developmental Cell 13, 254–267, August 2007 ª2007 Elseand overexpression of either gene can rescue aspects of
the clo vascular or hematopoietic phenotype (Liao et al.,
1998; Dooley et al., 2005; Sumanas et al., 2005; Sumanas
and Lin, 2006).
To determine whether scl and etsrp are required to re-
press cardiogenesis, we used previously characterized
anti-scl and anti-etsrp morpholinos (MOs) to knock
down gene function (Juarez et al., 2005; Sumanas and
Lin, 2006). Embryos injected with anti-scl or anti-etsrp
MOs displayed weak expression of hand2 in the rostral
ALPM (Figures 6A–6C). Injection of both anti-scl and
anti-etsrp MOs (hereafter referred to as anti-scl+etsrp
MOs) elicited strong rostral expression of hand2
(Figure 6D), similar to that observed in clo mutants
(Figure 5B). Additionally, injection of anti-scl+etsrp MOs
resulted in rostral extension of cmlc2 expression (Figures
6E and 6F), formation of a misshapen heart with an en-
larged atrium (Figures 6G and 6H), and production of too
many cardiomyocytes (Figure 6I), all of which are reminis-
cent of the clo mutant phenotype (Figures 5E–5H and 5K).
Conversely, overexpression of scl and etsrp induces ec-
topic expression of rostral ALPM markers, like fli1a, in
the HFR (Figures 7A–7C), reduces hand2 expression
(Figures 7D–7F), and decreases cardiomyocyte produc-
tion (Figures 7G–7I). Together, these data show that scl
and etsrp, both of which function downstream of clo to
promote vasculogenesis and hematopoiesis, are also es-
sential to override the latent cardiac developmental poten-
tial residing within rostral ALPM and thereby limit heart
size.
DISCUSSION
Taken together, our data reveal a previously unrecognized
mechanism for limiting heart size: components of the ves-
sel and blood specification pathways repress formation of
cardiac progenitors and thereby restrict the dimensions of
the heart-forming region. In the early zebrafish embryo,
the entire ALPM possesses cardiac developmental poten-
tial. However, not all of this potential is fulfilled. Only the
hand2-expressing portion of the ALPM produces myocar-
dium, whereas the rostral territory gives rise to endothe-
lium and myeloid cells. We find that this subdivision of
the ALPM is mediated by clo and its downstream effectors
scl and etsrp. In addition to promoting vessel and blood
specification, these genes also inhibit cardiac specifica-
tion within rostral ALPM. Thus, the induction of vessel
and blood lineages creates a rostral boundary for cardio-
genesis within a larger heart field.
Our findings indicate a close relationship between myo-
cardial, endothelial, and hematopoietic lineages during
their development. Consistent with this, several studies
in mouse have indicated a common origin for multiple car-
diovascular lineages. Lineage analysis in vivo and analysis
of progenitor differentiation in vitro have suggested that
myocardial, endothelial, and hematopoietic lineages
share a common progenitor expressing Flk1 (Ema et al.,
2006; Motoike et al., 2003), and recent experiments em-
ploying ES cell differentiation in vitro have shown thatvier Inc.
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Rostral ALPM Is Revealed by Inhibition
of Vasculogenesis and Myelopoiesis
(A–H) In situ hybridization depicts expression
of hand2 (A–D) and cmlc2 (E–H) in wild-type
(A, E, and G) and MO-injected (B–D, F, and H)
embryos. The scale bars represent 100 mm.
(A–F) Dorsal views, anterior to the top, at the 7
somite (A–D) and 20 somite (E and F) stages.
(G and H) Frontal views, dorsal to the top, at 48
hpf.
(A–D) hand2 is ectopically expressed in the
rostral ALPM of embryos when scl and etsrp
are knocked down. Injections of anti-scl (B) or
anti-etsrp (C) MOs caused weak expression
of hand2 in rostral ALPM (arrows; anti-scl
MOs, n = 6/10; anti-etsrp MOs, n = 6/12). Ros-
tral hand2 expression was not observed in
control sibling embryos (n = 0/24). Injection of
anti-scl+etsrp MOs (D) caused robust expres-
sion of hand2 in rostral ALPM (arrows; strong
expression, n = 10/17; weak expression, n =
7/17). Thus, injection of anti-scl+etsrp MOs
phenocopies a loss of clo function.
(E and F) Injection of anti-scl+etsrpMOs causes a rostral extension ofcmlc2 expression (arrows; injected embryos, n = 25/31; control siblings, n = 0/33).
(G and H) Injection of anti-scl+etsrp MOs results in cardiac chamber morphology resembling that of clo mutants (injected embryos, n = 8/10; control
siblings, n = 0/15).
(I) Hearts of anti-scl+etsrp MO-injected embryos contain too many cardiomyocytes. Counting of cardiomyocyte nuclei reveals statistically significant
increases (asterisks) in the total number of cardiomyocytes and the number of atrial cardiomyocytes in MO-injected embryos (p < 0.0002, Student’s t
test; n = 13 uninjected controls and 15 injected embryos). The bar graph indicates mean and standard error of each data set.Flk1-expressing progenitors give rise to myocardium, en-
dothelium, and vascular smooth muscle (Kattman et al.,
2006). Other complementary experiments indicate that
myocardium, endothelium, and vascular smooth muscle
can all arise from progenitors expressing Isl1, Nkx2-5,
and Flk1 (Moretti et al., 2006). Despite the wealth of
evidence supporting the existence of multipotent cardio-
vascular progenitors, it is not yet understood how individ-
ual progenitors become committed to distinct cardiovas-
cular fates. Our work sheds light on the regulation of these
lineage decisions: induction of genes such as scl and etsrp
is a critical mechanism, not only for promoting vascu-
logenesis and hematopoiesis but also for repressing
cardiogenesis.
The precise molecular interface between the vessel,
blood, and cardiac specification pathways will be an
important focus for future studies. It is possible that
Scl and/or Etsrp could be directly involved in repressing
expression of myocardial genes. Scl can act either as
a repressor or an activator depending on the context
of its protein-protein interactions (Lecuyer and Hoang,
2004), and in vitro assays have suggested that Scl is
capable of repressing muscle differentiation by disrupt-
ing the activities of other bHLH transcription factors
(Hofmann and Cole, 1996). However, the relationship
between specification pathways could also be less di-
rect and more complex, with genes downstream of Scl
and Etsrp repressing genes upstream of those required
for myocardial specification. Elucidation of the partners
and targets of Scl and Etsrp will help to illuminate the
transcriptional networks that link cardiovascular specifi-
cation pathways.DevelopIn addition to revealing an important interaction be-
tween cardiovascular pathways, our studies highlight the
developmental plasticity inherent to the rostral portion of
the zebrafish ALPM. The rostral ALPM has previously
been implicated in facilitating repair of the zebrafish HFR
following its partial ablation (Serbedzija et al., 1998). The
multipotency of the zebrafish rostral ALPM also suggests
an appealing mechanism for facilitating the alteration of
heart size and structure during the course of vertebrate
evolution. The amniote heart is significantly larger and
more complex than the teleost heart, but it is not yet clear
what regulatory changes made these structural modifica-
tions possible (Olson, 2006). A recent study in Ciona has
indicated that the addition of more cells to the myocardial
progenitor pool can provide opportunities for structural
innovation, such as the addition of a cardiac chamber
(Davidson et al., 2006). Our findings suggest that a reser-
voir of latent cardiac potential, akin to that found in the
zebrafish rostral ALPM, could have provided the raw ma-
terial necessary to elaborate upon the evolving heart. Even
slight changes in the regulation of anterior vasculogenesis
and hematopoiesis could have exposed a new source of
myocardial progenitors in an ancestral vertebrate. This
surplus could have led to augmentation of the HFR, allow-
ing development of a larger organ, as seen in our experi-
ments. Furthermore, we speculate that changes in utiliza-
tion of a latent reservoir of cardiac potential could have
provided the origin of the amniote second heart field, al-
lowing enhanced structural complexity through the addi-
tion of new cardiac chambers.
In conclusion, our data reveal an important regula-
tory relationship between cardiovascular specificationmental Cell 13, 254–267, August 2007 ª2007 Elsevier Inc. 263
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etsrp Promotes Vasculogenesis and
Inhibits Heart Formation
In situ hybridization depicts expression of fli1a
(A–C), hand2 (D–F), and cmlc2 (G–I) in wild-
type (A, D, and G) and scl+etsrp RNA-injected
embryos displaying severe (B, E, and H) and
moderate (C, F, and I) phenotypes. Dorsal
views, anterior to the top, at the 7 somite (A–
F) and 30 hpf (G–I) stages. The scale bars rep-
resent 100 mm.
(A–C) Overexpression of scl and etsrp induces
ectopic expression of fli1a, including expres-
sion within the HFR (arrowheads; severe phe-
notype, n = 7/15; moderate phenotype, n = 5/
15).
(D–F) RNA-injected embryos exhibit reduced
expression of hand2 (arrows; severe pheno-
type, n = 14/34; moderate phenotype, n = 15/
34).
(G–I) RNA-injected embryos exhibit small, dys-
morphic hearts (severe phenotype, n = 9/11;
moderate phenotype, n = 2/11).pathways. The repression of myocardial specification by
vascular and hematopoietic pathways coordinates devel-
opment of the cardiovascular system, both by regulating
the divergence of lineages from a common progenitor
and by restricting heart size. Importantly, our insight into
the interplay between cardiovascular pathways could
have a significant impact on strategies for regenerative
medicine. Specifically, our studies suggest that interfer-
ence with Scl and Etsrp function could be an effective
means of directing multipotent cardiovascular progenitor
cells toward myocardial differentiation. Thus, this work
will likely motivate new approaches for harnessing the de-
velopmental potential of cardiovascular progenitor cells to
facilitate cellular therapies for damaged cardiac muscle.
EXPERIMENTAL PROCEDURES
Mutations, Morpholinos, and RNA Injections
To generate mutant embryos, we intercrossed heterozygotes for the
mutations hans6 (Yelon et al., 2000), clos5 (Field et al., 2003), and closk4.
The closk4 allele was isolated as a spontaneous mutation in our zebra-
fish facility; closk4 mutants appear phenotypically identical to clos5
mutants.
All MOs used in our studies were previously characterized and
shown to be reasonably effective and specific (Juarez et al., 2005;
Sumanas and Lin, 2006). All MOs behaved as previously reported,
as assessed by the loss of vessels and blood. To knock down scl,
we injected 12.5 ng of a 2:3 mix of E2I2 and E3I3 anti-scl MOs (Juarez
et al., 2005). To knock down etsrp, we injected 12 ng of a 1:1 mix of
anti-etsrp MO1 and MO2 (Sumanas and Lin, 2006). For anti-scl+etsrp
MOs, we injected 12 ng of a 1:1 combination of the mixes described
above.264 Developmental Cell 13, 254–267, August 2007 ª2007 ElsevPreviously described plasmids were used to synthesize scl and
etsrp RNA (Dooley et al., 2005; Pham et al., 2007). Embryos were in-
jected with a combination of 40–50 ng of scl RNA and 4–8 ng of etsrp
RNA; injection of these amounts results in variable and mosaic pheno-
types but avoids toxicity and severe malformations.
All care and use of zebrafish and embryos complied with local animal
welfare laws, guidelines, and policies, as described in Animal Protocol
060911-01, approved by the New York University School of Medicine
Institutional Animal Care and Use Committee.
In Situ Hybridization
Single-color whole-mount in situ hybridization was performed as pre-
viously described (Yelon et al., 1999). Two-color fluorescent hybridiza-
tion was conducted according to a Yelon lab protocol that is optimized
for difficult riboprobes and is available upon request. Briefly, we used
pairs of riboprobes, one labeled with digoxigenin (DIG) and the other
labeled with dinitrophenol (DNP). DNP probes were synthesized as
previously described (Long and Rebagliati, 2002) using a DNP Label-
It kit (Mirus). DNP incorporation was enhanced by extending the label-
ing incubation to 2.5 hr and by using 1.5 ml of labeling reagent per mg of
RNA. Following probe hybridization, washes, and blocking, embryos
were incubated overnight at 4C with anti-DNP Fab fragments conju-
gated to horseradish peroxidase (HRP) (PerkinElmer; 1:400 dilution).
Embryos were then incubated with DNP tyramide (PerkinElmer; 1:25
dilution, 30 min at room temperature) to amplify DNP deposition.
Next, stringent conditions were used to insure removal of all HRP ac-
tivity. Embryos were washed in PBT (PBS, 0.1% Tween-20) containing
3% peroxide (four times, 15 min per wash) and then in 0.1 M glycine
(pH 2.2) with 0.1% Tween-20 (four times, 15 min per wash). Finally, em-
bryos were washed in PBT, blocked, and incubated overnight at 4C
with anti-DIG HRP-conjugated Fab fragments (Roche; 1:400 dilution).
Embryos were then incubated with fluorescein (FLU) tyramide (Perki-
nElmer), followed by removal of HRP activity, as above. Next, we con-
ducted a second round of tyramide deposition. Embryos were first
incubated with anti-DNP HRP-conjugated Fab fragments, followedier Inc.
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room temperature). After removal of HRP activity, embryos were incu-
bated with anti-FLU HRP-conjugated Fab fragments, followed by incu-
bation with FLU tyramide. After a final set of PBT washes, embryos
were stored in SlowFade Antifade solution (Invitrogen).
Photoactivation of Fluorescein in the ALPM
Caged fluorescein dextran was prepared and injected as previously
described (Keegan et al., 2004), with the exception of being injected di-
rectly into the single cell of newly fertilized embryos. When injected
embryos reached the 6–9 somite stage, they were mounted dorsal
side up in a well gouged from 2% agarose and filled with embryo water.
Caged fluorescein was photoactivated in clusters of 10–15 ALPM cells
by exposure to 1 s pulses from a 375 nm pulsed nitrogen laser (Micro-
point Laser System, Photonic Instruments). Laser light was focused
through a 403water immersion objective on a Zeiss Axioplan 2 micro-
scope equipped with a cooled CCD camera (Pentamax) and auto-
mated shutters (Uniblitz). For lateral ALPM labeling, we avoided label-
ing cells located more than four cell widths from the lateral edge of the
ALPM. To label medial ALPM, we labeled cells that were at least four
cell widths interior to the lateral edge of the ALPM.
Fluorescein Detection and Scoring of Labeled Cells
Labeled embryos were fixed at the desired stage: either immediately
(Figures 2E, 2F, 2H, and 2I), at 30 hpf (Figures 4G and 4H), or at 44
hpf (Figures 2J–2L and 5L). clo mutants were fixed at 44 hpf, our
lab’s standard stage for scoring labeled cells (Keegan et al., 2004).
However, han mutants were fixed at 30 hpf, as the han mutant myocar-
dium remains under the hindbrain at 44 hpf and is therefore obscured
by pigmentation. Wild-type data represent a combination of embryos
fixed at 30 and 44 hpf.
Following fixation, embryos were processed by in situ hybridization
to create a counterstain for fluorescein detection. For embryos fixed at
30 and 44 hpf, cmlc2 expression was visualized as previously de-
scribed (Keegan et al., 2004) using the substrate 5-bromo-6-chloro-
3-indolyl phosphate (magenta phos; B-5667, Sigma). Cells labeled
with uncaged fluorescein were then detected by immunohistochemis-
try and scored for tissue contributions based on location, morphology,
and counterstaining, as previously described (Keegan et al., 2004). In
particular, we used morphological criteria to distinguish myocardial
cells, which are relatively round and tend to be oriented circumferen-
tially around the heart, from endocardial cells, which are relatively elon-
gated and tend to project longitudinally. Additionally, we assessed lo-
calization of labeled cells relative to the myocardial counterstain. The
number of labeled progeny detected varied between individual em-
bryos. Contributions to pharyngeal pouches ranged between 5 and
50 cells and contributions to myocardium or endocardium ranged
between 1 and 30 cells.
For embryos fixed immediately after labeling, we used our two-color
fluorescent in situ hybridization technique to counterstain for ALPM
markers (scl or nkx2.5) and to detect uncaged fluorescein. Briefly,
DIG riboprobe was detected with anti-DIG HRP-conjugated Fab frag-
ments, incubation with DNP tyramide, and a second round of tyramide
depostion with anti-DNP HRP-conjugated Fab fragments and Cy3 tyr-
amide. Then, uncaged fluorescein was detected with anti-FLU HRP-
conjugated Fab fragments and a FLU tyramide reaction, with an op-
tional second round of tyramide deposition.
Cardiomyocyte Counting
To count cardiomyocytes, we employed the transgene
Tg(cmlc2:DsRed2-nuc) (Mably et al., 2003), as described in a separate
manuscript (J.S. Waxman, B.R.K., and D.Y., unpublished data). Briefly,
we processed transgenic embryos using a standard immunofluores-
cence protocol (Alexander et al., 1998), the primary antibodies S46
(anti-Amhc; 1:20; Developmental Studies Hybridoma Bank) and anti-
DsRed (1:4000; Clontech), and the secondary antibodies goat anti-
mouse IgG1 FITC (1:100; Southern Biotechnology Associates) andDevelopdonkey anti-rabbit Alexa 594 (1:1000; Invitrogen). We then counted
the red fluorescent nuclei in each cardiac chamber.
Imaging
Fluorescent in situ hybridization images were captured with a Zeiss
LSM 510 confocal microscope and processed with Zeiss LSM 510
and Adobe Photoshop 7 software. Capture of DIC and FITC images
of live embryos was controlled by Metamorph Imaging System soft-
ware (v6.1r3, Universal Imaging). All other embryos were photo-
graphed with Zeiss M2Bio and Axioplan microscopes outfitted with
Zeiss Axiocam digital cameras; images were processed with Zeiss
AxioVision (v3.0.6) and Adobe Photoshop 7 software.
Supplemental Data
Supplemental Data include one figure and are available at http://www.
developmentalcell.com/cgi/content/full/13/2/254/DC1/.
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